HYDI Hydromer Inc.

Hydromer Inc., Announces the Addition of Cam Cruickshank, Ph.D. to the Company’s Board of Directors, Replacing the Retiring Mr. Dieter Heinemann

Hydromer Inc., Announces the Addition of Cam Cruickshank, Ph.D. to the Company’s Board of Directors, Replacing the Retiring Mr. Dieter Heinemann

Concord, NC, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via  -- Hydromer, Inc. (the “Company”) (HYDI:OTC), a world-wide supplier of specialty coatings for medical devices and industrial applications, is excited to announce that Cam Cruickshank, Ph.D. has joined the Hydromer Board of Directors via unanimous vote. 

Cam Cruickshank, Ph.D. currently serves as the President of Cabarrus College of Health Sciences, a part of Advocate Health, which is the fifth-largest hospital network in the United States. Advocate Health has more than 150,000 employees, operates 67 hospitals, and offers more than 1,400 care locations in Alabama, Illinois, Georgia, North Carolina, South Carolina, and Wisconsin. Dr. Cruickshank works at Cabarrus College’s hospital campus located in Concord, North Carolina and has held this position since March 2020. Prior to this position, Dr. Cruickshank’s executive experience spans more than 15 years and includes serving various other executive roles for other institutions, as a consultant, and as an entrepreneur. 

Dr. Cruickshank is a person with strong financial acumen and takes much pride in managing operating budgets which finish the fiscal year favorable to budget. As the Chief Enrollment Officer at The University of Toledo, Cam was responsible for developing marketing, recruitment, financial aid, and retention strategies. While serving as the Chief Operating Officer at Madonna University, Dr. Cruickshank managed the University’s operating budget. 

Dr. Cruickshank brings extensive board room experience. In addition to more than 15 years of providing board presentations, his current board appointments include the Salvation Army of Greater Charlotte, the Cabarrus Healthcare Foundation, and the Cabarrus Entrepreneurship Council. Dr. Cruickshank utilizes his financial management experiences as a member of the Finance Committee of the Salvation Army of Greater Charlotte and the Investment Committee of the Cabarrus Healthcare Foundation. He also serves as an advisor and mentor for start-up companies in the areas of educational technology and higher education services. 

A native of Windsor, Ontario, Canada, Cam holds a Bachelor of Science degree from the University of Windsor, a Master of Education from Bowling Green State University, a Master of Business Administration from Tiffin University, and a doctoral degree in higher education administration from The University of Toledo. He lives in Huntersville, North Carolina with his wife Margarita and two of their four children.

Cam Cruickshank, Ph.D. serves as the fifth member of the Hydromer Board of Directors and is replacing Mr. Dieter Heineman (88) who steadfastly and loyally served on the Hydromer Board since 1991.  His resignation was not as a result with any disagreements with the Company or any matter related to the Company’s operations, policies, or practices. 

“With Hydromer’s proud 40-year track record of innovation and remarkable customer service in the growing and mission-critical world of medical device surface modification, we are excited to add Cam Cruickshank’s healthcare and financial expertise as a member of the Hydromer Board of Directors.  We also wish to gratefully thank Mr. Dieter Heinemann for his strong resolve, many powerful insights and great direction as an independent Board member over the last three decades,” said Peter M. von Dyck, Hydromer CEO.

About Hydromer®

Hydromer®, Inc & Subsidiary (the “Company”) is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer research & development, and manufacturing services capabilities for a wide variety of applications. We are a U.S. public corporation domiciled in Concord, NC. Our customers are located across the United States of America, Europe, and Asia-Pacific. The Company was established in 1980, originally incorporated in the State of New Jersey. We are a U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 production facility. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets, in a wide range of industries. We manage numerous global B2B services such as, coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and secured many patents worldwide at separate times throughout our history including, anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic and thromboresistant coatings. 



Attachment



EN
11/01/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydromer Inc.

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Thi...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end ...

 PRESS RELEASE

Hydromer, Inc. Announces the Restructuring and Formation of World-Clas...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development ·       Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions ·       Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologie...

 PRESS RELEASE

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Fin...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to ch...

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Fir...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-en...

 PRESS RELEASE

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Co...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) Hydromer, Inc. (the “Company”) is pleased to provide the following update to shareholders regarding the Company’s progress toward stability and profitable growth. Much has been done since the spring of 2023 in reducing the Company’s overhead and operating costs, which management believes will lead to improved profitability in the current fiscal year. Additionally, investment in new prod...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch